TCRx Therapeutics Co.Ltd
8 clinical trials · Sponsor
◉ Watch TCRx Therapeutics Co.Ltd
| Record | Firm | Date |
|---|---|---|
| Apheresis Collection for New Drug Development and Evaluation Research (NCT07663565) | TCRx Therapeutics Co.Ltd | 2026-06-22 |
| KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma) (NCT07596693) | TCRx Therapeutics Co.Ltd | 2025-12-19 |
| Personalized KXV01 Lentinvivo (TCR) Injection as the Therapy for Advanced Solid Tumors (NCT07275853) | TCRx Therapeutics Co.Ltd | 2025-12-01 |
| Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors (NCT07196579) | TCRx Therapeutics Co.Ltd | 2025-10-01 |
| KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT07260812) | TCRx Therapeutics Co.Ltd | 2025-09-01 |
| KSX01-TCRT Injection Project in Solid Tumors (NCT05811975) | TCRx Therapeutics Co.Ltd | 2023-03-07 |
| KSH01-TCRT Solid Tumors (NCT05539833) | TCRx Therapeutics Co.Ltd | 2022-08-19 |
Track TCRx Therapeutics Co.Ltd automatically
Every clearance here is in the API, with alerts when new ones post.